UCLA BSCRC Researchers Explain Study

In a specially designed facility that is compliant with FDA Good Manufacturing Practices (GMP) requirements, scientists with the Eli and Edythe Center of Regenerative Medicine and Stem Cell Research at UCLA have taken human skin cells, reprogrammed them to be pluripotent and then differentiated them into neurons, using animal origin-free reagents and feeder conditions throughout the process. This is the first time scientists have been able to derive potentially clinically usable induced pluripotent stem (iPS) cells and differentiate them into neurons in animal origin-free derivation and differentiation conditions using commercially available reagents to facilitate broad application.